Lisata Therapeutics, Inc. Common Stock

LSTANASDAQ • USD
ThemeHealthcare - Oncology›Targeted Therapy & Precision Oncology
1.69 USD
↘ 0.13 (7.14%)AT CLOSE (11:59 AM EDT)
1.65
↘ 0.04 (2.37%)
POST MARKET (AS OF 07:28 PM EDT)
Post Market
AS OF 07:28 PM EDT
1.65
↘ 0.04 (2.37%)
🔴Market: CLOSED

Lisata Therapeutics, Inc. Common Stock (LSTA) is currently trading at $1.69. The technical outlook is "Neutral" and the fundamental picture shows "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. LSTA is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Aug 28, 2026.

Open?$1.80
High?$1.82
Low?$1.54
Prev. Close?$1.82
Volume?245.0K
Avg. Volume?387.7K
VWAP?$1.66
Rel. Volume?0.63x
Bid / Ask
Bid?$1.37 × 100
Ask?$2.00 × 100
Spread?$0.63
Midpoint?$1.69
Valuation & Ratios
Market Cap?15.2M
Shares Out?9.0M
Float?7.2M
Float %?79.1%
P/E Ratio?N/A
P/B Ratio?1.85
EPS?-$1.62
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.
Themes
Healthcare - Oncology›Targeted Therapy & Precision OncologyBiotech - Drug Development›Clinical-Stage Platforms
Employees
21
Market Cap
15.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.lisata.com
Listed
1999-03-01
Address
110 ALLEN ROAD
BASKING RIDGE, NJ 07920
Phone: 908-229-2590
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
65
Short Sent.?
60
Piotroski F-Score?0/9Weak
Altman Z-Score?-73.66Distress
Confidence?49%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.25%Low
Short Interest?89.9K
Days to Cover?1.1
Free Float7.2M
Avg Daily Volume78.7K
Settlement Date2026-08-14
Financial Health
Current Ratio?3.69Strong
Quick Ratio?3.69Strong
Cash Ratio?3.50Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
78
1.85CHEAP▾
P/S?
Peers
100
S&P
3
152.28HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.3CHEAP▾
EV/Sales?
Peers
100
S&P
3
47.85HIGH▾
Returns & Efficiency
ROE?
S&P
3
-177.4%WEAK▾
ROA?
S&P
3
-132.6%WEAK▾
Cash Flow & Enterprise
FCF?$-12323000
Enterprise Value?$4.8M
Fundamentals ratios updated end of day
MarketsMoversWatchlist